HomeAI · summaries
Storia in 2 fonti
South Africa’s iDexis appeals court ruling over compounded weight-loss drugs
JOHANNESBURG: South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production of compounded weight-loss medicines, disputing allegations about product safety and regulatory compliance. The dispute follows a High Court interim order granted last month barring iDexis from manufacturing and selling GLP-1 medicines containing semaglutide, in a case brought by Novo Nordisk and comes amid heightened scrutiny of compounded versions of popular weight-loss and diabetes treatments.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
arabnews.com
South Africa’s iDexis appeals court ruling over compounded weight-loss drugs
JOHANNESBURG: South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production of compounded weight-loss medicines,…
- ·
businessday.co.za
iDexis seeks leave to appeal interim order on GLP-1 production
Pharma group vows to pursue other legal remedies if appeals against authorities fail